Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arvinas, Inc. - Common Stock (NQ:ARVN)

7.720 +0.490 (+6.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,597,382
Open 7.290
Bid (Size) 7.650 (14)
Ask (Size) 7.700 (2)
Prev. Close 7.230
Today's Range 6.800 - 8.000
52wk Range 5.935 - 37.38
Shares Outstanding 73,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Apple To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Here are the top movers in Thursday's session.
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill

Performance

YTD
-59.1%
-59.1%
1 Month
+7.5%
+7.5%
3 Month
-56.2%
-56.2%
6 Month
-71.3%
-71.3%
1 Year
-76.2%
-76.2%

More News

Read More
Top stock movements in today's session.
Via Chartmill
Earnings Scheduled For May 1, 2025
Via Benzinga
Dow Surges Over 300 Points; McDonald's Posts Weak Revenue
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Thursday's session.
Via Chartmill
Nasdaq Jumps 1.5%; Microsoft Posts Upbeat Results
Via Benzinga
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Arvinas Inc.
Via GlobeNewswire
A Peek at Arvinas's Future Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
From Arvinas Inc.
Via GlobeNewswire
Arvinas Shares New Preclinical Combination Data for the PROTAC BCL6 Degrader, ARV-393, at the 2025 American Association for Cancer Research Annual Meeting
From Arvinas Inc.
Via GlobeNewswire
Arvinas Announces Results from the VERITAC-2 Trial Selected as Late-Breaking Oral Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
From Arvinas Inc.
Via GlobeNewswire
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting
From Arvinas Inc.
Via GlobeNewswire
Arvinas Potential Parkinson's Treatment Shows Positive Data In Human Study
Via Benzinga
Arvinas Presents First-in-Human Data for Investigational Oral PROTAC ARV-102 Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation
From Arvinas Inc.
Via GlobeNewswire
Arvinas Announces Oral Presentation at 2025 International Conference on Alzheimer’s & Parkinson’s Diseases
From Arvinas Inc.
Via GlobeNewswire
Top 3 Health Care Stocks That Are Set To Fly This Month
Via Benzinga
Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial
Via Benzinga

Frequently Asked Questions

Is Arvinas, Inc. - Common Stock publicly traded?
Yes, Arvinas, Inc. - Common Stock is publicly traded.
What exchange does Arvinas, Inc. - Common Stock trade on?
Arvinas, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Arvinas, Inc. - Common Stock?
The ticker symbol for Arvinas, Inc. - Common Stock is ARVN on the Nasdaq Stock Market
What is the current price of Arvinas, Inc. - Common Stock?
The current price of Arvinas, Inc. - Common Stock is 7.720
When was Arvinas, Inc. - Common Stock last traded?
The last trade of Arvinas, Inc. - Common Stock was at 05/02/25 04:00 PM ET
What is the market capitalization of Arvinas, Inc. - Common Stock?
The market capitalization of Arvinas, Inc. - Common Stock is 563.56M
How many shares of Arvinas, Inc. - Common Stock are outstanding?
Arvinas, Inc. - Common Stock has 564M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.